Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.21+0.01 (+6.06%)
Close on Nov 17, 2026Market cap $947.51KP/E –Yield –
Oragenics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Oragenics's operating cash flow for the twelve months ending Jun 30, 2026 was -$10.21M. For fiscal 2025 it was -$9.25M. The highest annual figure on record is -$5.19M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.25M | – |
| FY2024 | Dec 31, 2024 | -$8.60M | – |
| FY2023 | Dec 31, 2023 | -$7.29M | – |
| FY2022 | Dec 31, 2022 | -$15.23M | – |
| FY2021 | Dec 31, 2021 | -$13.47M | – |
| FY2020 | Dec 31, 2020 | -$16.95M | – |
| FY2019 | Dec 31, 2019 | -$13.01M | – |
| FY2018 | Dec 31, 2018 | -$9.08M | – |
| FY2017 | Dec 31, 2017 | -$6.36M | – |
| FY2016 | Dec 31, 2016 | -$7.08M | – |
| FY2015 | Dec 31, 2015 | -$5.19M | – |
| FY2014 | Dec 31, 2014 | -$5.56M | – |
| FY2013 | Dec 31, 2013 | -$6.76M | – |
| FY2012 | Dec 31, 2012 | -$5.21M | – |
| FY2011 | Dec 31, 2011 | -$5.49M | – |
| FY2010 | Dec 31, 2010 | -$6.45M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.19M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.84M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.98M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.11M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.02M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.97M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.54M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.06M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.10M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.50M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.58M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.43M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.78M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.38M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.64M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.48M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.08M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.33M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.63M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.67M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.83M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.82M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.94M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.38M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.49M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.21M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.98M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.45M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.28M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.37M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.36M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.34M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.77M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.90M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.96M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.57M | – |
See a number that looks wrong?